Sign in
4/A

Changes in Ownership

Xilio Therapeutics, Inc. Filed Acc 0000899243-21-042710

10% owner bought 625,000 shares at $16.00 ($10,000,000)

  • 10% owner acquired 2,602,264 shares (conversion)

From the SEC's structured data for this filing

Trades in this filing

SV7 Impact Medicine Fund LP · 10% owner

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2021-10-26 Conversion : show line 1 in the form +998,544 998,544 D
2021-10-26 Conversion : show line 2 in the form +998,544 998,544 I
2021-10-26 Conversion : show line 3 in the form +302,588 1,301,132 D
2021-10-26 Conversion : show line 4 in the form +302,588 1,301,132 I
2021-10-26 Purchase : show line 5 in the form +312,500 $16.00 $5,000,000 1,613,632 D
2021-10-26 Purchase : show line 6 in the form +312,500 $16.00 $5,000,000 1,613,632 I
Open-market purchases · 625,000 sh · avg $16.00 · $10,000,000

Table II: Derivative

4 lines
Date Transaction Shares Owned after D/I
2021-10-26 Conversion : show line 7 in the form Series B Convertible Preferred Stock −9,486,166 0 D
2021-10-26 Conversion : show line 8 in the form Series B Convertible Preferred Stock −9,486,166 0 I
2021-10-26 Conversion : show line 9 in the form Series C Convertible Preferred Stock −2,874,595 0 D
2021-10-26 Conversion : show line 10 in the form Series C Convertible Preferred Stock −2,874,595 0 I
Loading xslF345X03/doc4a.xml…